- Tekcapital has acquired the exclusive license to a patent for the measurement of glucose in saliva from Arizona State University.

The patent, # 8815178 B2, addresses the need for a safe, fast and non-invasive method and device to collect and sample glucose in saliva.

The device allows trace fluid samples from a biological surface to be obtained for electrochemical analysis and the subsequent detection of analytes.

The device can be used to collect fluid from the mouth and for such samples to be subsequently processed to detect glucose, a metabolic product in saliva, using disposable biosensor strips.

The Directors believe this technology represents an important potential improvement for the repeated measurement of glucose in Type II diabetics, without requiring a blood sample from a finger prick, which is the current FDA standard glucometer method of measurement.

According to the World Health Organization, about 347 million people worldwide have diabetes (~ 9% of the world's population). There is an emerging global epidemic of diabetes that can be traced back to rapid increases in overweight, including obesity and physical inactivity.

Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin, a hormone that regulates blood sugar, or when the body cannot effectively use the insulin it produces.

Hyperglycaemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body's systems, especially the nerves and blood vessels.

Story provided by